OUR GROUP
An independent Group committed to therapeutic progress to serve patient needs
35th
LARGEST PHARMACEUTICAL
COMPANY WORLDWIDE
and 2nd largest pharmaceutical Group
in France*
130+
COUNTRIES in which
the Group’s medicines
are distributed
100
MILLION PATIENTS
treated each day worldwide with
Group medicines.
20000+
EMPLOYEES
*IQVIA, Analytics Link / World 82 countries – MAT Q3-2025
SERVIER, A Global Pharmaceutical Group
Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle.
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D.
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.
Our Vocation
We are committed to therapeutic progress to serve patient needs.
Our Vision
Founded to serve health, our Group aspires to make a meaningful social impact for patients and for a sustainable world.
Our Values
CARE
DARE TO INNOVATE
GROW BY SHARING
COMMIT TO SUCCEED
1st
Leading Pharmaceutical Group in
Hypertension Worldwide*
4.35/5
Overall Engagement Score Achieved by
the Servier Group***
13
Production Sites
86%
of Employees Would Recommend Servier as a Great Place to Work
Source : annual engagement survey conducted
with the Gallup Institute – 2024 Group results***
5th
Leading Pharmaceutical Group in
Cardiology Worldwide*
*IQVIA, Analytics Link / World 82 countries – MAT Q3-2025
** Scope 1 emissions represent emissions directly linked to Group operations. Scope 2 emissions are linked to the purchase of electricity and energy for heating or cooling
*** Source: annual engagement survey conducted with the Gallup Institute – 2025 Group results of electricity and energy for heating or cooling
Research & Innovation
We have everything we need at our disposal to actively contribute to therapeutic progress, including a long-term vision, made possible by our unique governance model, an effective and collaborative approach to innovation, significant investment in R&D and a presence in the heart of global innovation communities. We have chosen to focus our R&D efforts on therapeutic areas where medical needs remain considerable and are not yet tackled taking the increasingly targeted approach of precision
medicine.
More about Research & Innovation at Servier
Top 10
Servier makes it into the top 10
(of 46 companies) among patient
organizations working and/or familiar
with the Servier Group
1st
Ranked 1st out of 28 companies
by oncology patient
organizations
Source: PatientView Report
2024 on the reputation
of pharmaceutical companies
R&D Pipeline
36 projects in clinical development
(including 14 new
molecular entities)
and 24 research projects (June 2025)
Partnering with Servier
At Servier, partnering is at the heart of our innovation strategy with bold short-term objectives as part of our long-term ambition. We are a highly committed and experienced team focused on partnerships to further innovate for patients.
Partnering is a key enabler for our 2030 ambition and beyond.
A Strong Industrial Network
At our 13 production sites located throughout the world, we produce and distribute our medicines to the highest standards on quality, safety, and reliability.
By harnessing digital innovation across the entire value chain, we continue to enhance our agility to meet patient demand.
Sustainability
Sustainability is rooted in our vocation as a pharmaceutical Group committed to therapeutic progress to serve patient needs. As a Group governed by a foundation, we naturally adopt a long-term perspective that shapes our decisions and actions. We maximize our health impact by serving Patients, People and the Planet.
Find out more
https://servier.com/en/our-commitments/
Mécénat Servier Charity Fund supports international initiatives in the fields of health, education, culture, living together and humanitarian aid. More information: https://mecenat.servier.com/